Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 5 November 2009, Vol. 114, No. 19, pp. 4158-4168.
Prepublished online as a Blood First Edition Paper on August 20, 2009; DOI 10.1182/blood-2008-12-192583.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Tables and Figures
Right arrow All Versions of this Article:
blood-2008-12-192583v1
114/19/4158    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Li, Z.
Right arrow Articles by Morris, S. W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Z.
Right arrow Articles by Morris, S. W.
Related Collections
Right arrow Lymphoid Neoplasia
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

LYMPHOID NEOPLASIA

Eµ-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-{kappa}B pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma

Zhaoyang Li1,*, Hongsheng Wang1,*, Liquan Xue2,*, Dong-Mi Shin1, Derry Roopenian3, Wu Xu4, Chen-Feng Qi1, Mark Y. Sangster5, Carlos J. Orihuela6, Elaine Tuomanen7, Jerold E. Rehg2, Xiaoli Cui2, Quangeng Zhang8, Herbert C. Morse, III1, and Stephan W. Morris2

1 Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD; 2 Departments of Pathology and Oncology, St Jude Children's Research Hospital, Memphis, TN; 3 The Jackson Laboratory, Bar Harbor, ME; 4 Department of Chemistry, University of Louisiana at Lafayette; 5 Department of Microbiology, University of Tennessee at Knoxville; 6 Department of Microbiology and Immunology, University of Texas Health Science Center at San Antonio; 7 Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN; and 8 Department of Immunology, Capital Medical University, Beijing, People's Republic of China

BCL10, required for nuclear factor {kappa}B (NF-{kappa}B) activation during antigen-driven lymphocyte responses, is aberrantly expressed in mucosa-associated lymphoid tissue-type marginal zone (MZ) lymphomas because of chromosomal translocations. Eµ-driven human BCL10 transgenic (Tg) mice, which we created and characterize here, had expanded populations of MZ B cells and reduced follicular and B1a cells. Splenic B cells from Tg mice exhibited constitutive activation of both canonical and noncanonical NF-{kappa}B signaling pathways is associated with increased expression of NF-{kappa}B target genes. These genes included Tnfsf13b, which encodes the B-cell activating factor (BAFF). In addition, levels of BAFF were significantly increased in sera from Tg mice. MZ B cells of Tg mice exhibited reduced turnover in vivo and enhanced survival in vitro, indicative of lymphoaccumulation rather than lymphoproliferation as the cause of MZ expansion. In vivo antibody responses to both T-independent, and especially T-dependent, antigens were significantly reduced in Tg mice. Mortality was accelerated in Tg animals, and some mice older than 8 months had histologic and molecular findings indicative of clonal splenic MZ lymphoma. These results suggest that, in addition to constitutive activation of BCL10 in MZ B cells, other genetic factors or environmental influences are required for short latency oncogenic transformation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020